Sino Biopharmaceutical to acquire LaNova Medicines for up to $951m

Sino Biopharmaceutical to acquire LaNova Medicines for up to $951m

U.S. dollar banknotes are seen in this illustration taken May 4, 2025. REUTERS/Dado Ruvic/Illustration

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter